Cell cycle control of ovarian granulosa cells in tumors and cysts

International Journal of Surgical Pathology

Volumn 4, Issue 2, 1996, Pages 61-69

  Costa, Michael J ^a   Walls, Judy ^a   Dickerman, Alexandra ^a   Ames, Peter F ^a   Roth, Lawrence M ^b   Guinee Jr , Donald ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Ki67 (MIB 1); p21(CIP1 Waf1); p53; Proliferation; Sex cord stromal tumors

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CYST; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029982895     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689699600400201     Document Type: Article

References (44)

1. Vogelstein B, Kinzler KW. p53 function dysfunction. Cell 70:523-526, 1992
2. Marx J. How p53 suppresses cell growth. Science 262:1644-1645, 1993
3. Harris CC. p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980-1981, 1993
4. Jensen RA, Page DL. p53: The promising story continues to unfold. Hum Pathol 455-456, 1993
5. Ell-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
6. 1 arrest and apoptosis. Cancer Res 54:1169-1174, 1994
7. Zhang W, Grasso L, McClain CD. p53-independent induction of WAF/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55:668-674, 1995
8. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395, 1994
9. Gudas J, Nguyen H, Li T, Hill D, Cowan KH. Effects of cell cycle, wild-type p53 and DNA damage on p21 CIP/Waf1 expression in human breast epithelial cells. Oncogene 11:253-261, 1995
10. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, DOKO GP. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci 92:5451-5455, 1995
11. Chiarugi V, Magnelli L, Cinelli M, Basi G. Apoptosis and the cell cycle. Cell Molec Bio Res 40:603-612, 1994
12. Gerdes J, Li L, Schlueter C, Duchrow M, Wolenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H-D. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873, 1991
13. Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363, 1992
14. Barbareschi M, Girlando S, Mauri FM, Forti S, Eccher C, Mauri FA, Togni R, Dalla Palma P, Doglioni C. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 102:171-175, 1994
15. DeLellis RA. Does the evaluation of proliferative activity predict malignancy or prognosis in endocrine tumors. Hum Pathol 26:131-134, 1995
16. Taylor CR, Shi SR, Chaiwun B, Young L, Imam SA, Cote R J. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin section: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen and Ki67 antigen revealed by antigen retrieval techniques. Hum Pathol 25:263-270, 1994
17. Fox H. Sex cord-stromal tumors of the ovary. J Pathol 145:127-148, 1985
18. Young RH, Scully RE. Ovarian sex cord-stromal tumors: Recent progress. Int J Gynecol Pathol 1:101-123, 1982
19. Young RH, Scully RE. Ovarian sex cord-stromal tumors. Problems in differential diagnosis. Pathol Annu 23 ptI:237-296, 1988
20. Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer 35:231-241, 1975
21. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary: A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7:136-152, 1979
22. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol 11:261-274, 1981
23. Zaloudek C, Norris H. Granulosa tumors of the ovary in children: A clinical and pathologic study of 32 cases. Am J Surg Pathol 6:513-522, 1982
24. Evans AT, Gaffey TA, Malkasian GD, Annegers JF: Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 55:231-238, 1980
25. Dempster J, Giersson, Duncan ID. Survival after granulosa and theca cell tumors. Scot Med J 32:38-39, 1987
26. Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol 52:50-55, 1994
27. Haba R, Miki H, Kobayashi S, Ohmori M. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor. Cancer 72:3258-3262, 1993
28. Klemi PJ, Joensuu H, Salmi T. Prognostic value of flow cytometric DNA content analysis in granulosacelltumoroftheovary. Cancer 65:1189-1193, 1990
29. Jacoby AF, Young RH, Colvin RB, FloKe TJ, Preffer F, Scully RE, Swymer CM, Bell DA. DNA content in juvenile granulosa cell tumors of the ovary: A study of early- and advanced-stage disease. Gynecol Oncol 46:97-103, 1992
30. Bell DA. Flow cytometry of ovarian neoplasms. Curr Topics Pathol 85:337-356, 1992
31. Swanson SA, Norris HJ, Kelsten ML, Wheeler JE. DNA content of juvenile granulosa tumors determined by flow cytometry. Int J Gynecol Pathol 9:101-109, 1990
32. Chadha S, Cornelisse CJ, Schaberg A. Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors. Gynecol Oncol 36:240-245, 1990
33. Kwang-Sun S, Silverberg SG, Rhame JG, Wilkinson DS. Granulosa cell tumor of the ovary: Histopathologic and flow cytometry analysis with clinical correlation. Arch Pathol Lab Med 114:496-501, 1990
34. Hitchcock CL, Norris HJ, Khalifa MA, Wargotz ES. Flow cytometric analysis of granulosa tumors. Cancer 64:2127-2132, 1989
35. Klemi PJ, Takahashi S, Joensuu H, Kiilholma P, Narimatsu E, Mori M. Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int J aynecol Pathol 13:228-233, 1994
36. Bosari S, Viale G, Radaelli U, Bossi P, Bonoldi E, Coggi G. p53 accumulation in ovarian carcinomas and its prognostic implications. Hum Pathol 24:1175-1179, 1993
37. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103-3108, 1993
38. Kohler MF, Kerns BJ, Humphrey PA, Marks JR, Bast RC Jr, Berchuck A. Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81:643-650, 1993
39. Kounelis S, Papadaki H, Kanbour-Shakir A, Bakker, Swalsky PA, Finkelstein SD. p53 point mutational damage predicts tumor recurrence in ovarian adenocarcinoma. Mod Pathol 8:92A, 1995
40. Costa MJ, Walls J, Ames P, Roth LM. Transformation in recurrent ovarian granulosa cell tumors. Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 27:274-281, 1996
41. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa cell tumors: Absence of epithelial membrane antigen has diagnostic value. Hum Pathol 25:60-66, 1994
42. Clement PM. Ovary. In Sternberg SS (ed): Histology for pathologists. Raven Press, New York, pp. 765-792, 1991
43. Duncan RC, Knapp RG, Miller MC. Introductory biostatistics for the health sciences. J Wiley & Sons, New York, 1977
44. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawaoi A, Oyama T, Sugai T, Sasou S. Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochcmical staining procedure using monoclonal MIB-1. Hum Pathol 26:139-146, 1995